WallStreetZenWallStreetZen

NASDAQ: CROX
Crocs Inc Stock

$148.92+6.30 (+4.42%)
Updated May 24, 2024
CROX Price
$148.92
Fair Value Price
$262.47
Market Cap
$9.04B
52 Week Low
$74.00
52 Week High
$150.72
P/E
11.45x
P/B
5.66x
P/S
2.17x
PEG
1.61x
Dividend Yield
N/A
Revenue
$4.02B
Earnings
$795.48M
Gross Margin
56.2%
Operating Margin
25.59%
Profit Margin
19.8%
Debt to Equity
2
Operating Cash Flow
$893M
Beta
1.59
Next Earnings
Jul 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CROX Overview

Crocs, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for men, women, and children. It offers various footwear products, including clogs, sandals, slides, flip-flops, boots, flats, wedges, platforms, socks, shoe charms, loafers, sneakers, and slippers under the Crocs brand name. The company sells its products in approximately 85 countries through wholesalers, retail stores, e-commerce sites, and third-party marketplaces. As of December 31, 2021, it had 193 outlet stores, 107 retail stores, 373 company-operated stores, 73 kiosks and store-in-stores, and 14 company-operated e-commerce sites. The company serves in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. Crocs, Inc. was founded in 1999 and is headquartered in Broomfield, Colorado.

Zen Score

Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CROX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CROX ($148.92) is undervalued by 43.26% relative to our estimate of its Fair Value price of $262.47 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CROX ($148.92) is significantly undervalued by 43.26% relative to our estimate of its Fair Value price of $262.47 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CROX ($148.92) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CROX due diligence checks available for Premium users.

Be the first to know about important CROX news, forecast changes, insider trades & much more!

CROX News

Valuation

CROX fair value

Fair Value of CROX stock based on Discounted Cash Flow (DCF)
Price
$148.92
Fair Value
$262.47
Undervalued by
43.26%
CROX ($148.92) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CROX ($148.92) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CROX ($148.92) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CROX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
11.45x
Industry
29.22x
Market
32.03x
CROX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CROX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CROX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.66x
Industry
7.5x
CROX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CROX price to earnings growth (PEG)

For valuing profitable companies with growth potential
CROX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CROX's financial health

Profit margin

Revenue
$938.6M
Net Income
$152.5M
Profit Margin
16.2%
CROX's Earnings (EBIT) of $1.03B... subscribe to Premium to read more.
Interest Coverage Financials
CROX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.8B
Liabilities
$3.2B
Debt to equity
2
CROX's short-term assets ($1.11B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CROX's long-term liabilities ($2.57B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CROX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CROX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$27.6M
Investing
-$15.8M
Financing
$54.8M
CROX's operating cash flow ($892.94M)... subscribe to Premium to read more.
Debt Coverage Financials

CROX vs Shoe Stocks

TickerMarket Cap1d %P/EP/B
CROX$9.04B+4.42%11.45x5.66x
BIRK$9.04B+3.93%N/A3.38x
SKX$10.42B+1.35%17.74x2.51x
ONON$12.96B+4.74%93.78x9.97x
SHOO$3.14B+3.35%17.41x3.81x

Crocs Stock FAQ

What is Crocs's quote symbol?

(NASDAQ: CROX) Crocs trades on the NASDAQ under the ticker symbol CROX. Crocs stock quotes can also be displayed as NASDAQ: CROX.

If you're new to stock investing, here's how to buy Crocs stock.

What is the 52 week high and low for Crocs (NASDAQ: CROX)?

(NASDAQ: CROX) Crocs's 52-week high was $150.72, and its 52-week low was $74.00. It is currently -1.19% from its 52-week high and 101.24% from its 52-week low.

How much is Crocs stock worth today?

(NASDAQ: CROX) Crocs currently has 60,702,500 outstanding shares. With Crocs stock trading at $148.92 per share, the total value of Crocs stock (market capitalization) is $9.04B.

Crocs stock was originally listed at a price of $14.28 in Feb 8, 2006. If you had invested in Crocs stock at $14.28, your return over the last 18 years would have been 943.22%, for an annualized return of 13.91% (not including any dividends or dividend reinvestments).

How much is Crocs's stock price per share?

(NASDAQ: CROX) Crocs stock price per share is $148.92 today (as of May 24, 2024).

What is Crocs's Market Cap?

(NASDAQ: CROX) Crocs's market cap is $9.04B, as of May 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Crocs's market cap is calculated by multiplying CROX's current stock price of $148.92 by CROX's total outstanding shares of 60,702,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.